Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Zerr

Showing results (281-290 of 358) with videos related to

Pageof 36
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2021
Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In VivoTobias Thom, Matthias Schmitz, Anna-Lisa Fischer, et al.
Molecular Neurobiology|October 12, 2016
Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform EncephalopathiesAgata Mata, Laura Urrea, Silvia Vilches, et al.
Human Molecular Genetics|April 9, 2016
Identification of new molecular alterations in fatal familial insomniaFranc Llorens, Katrin Thüne, Matthias Schmitz, et al.
Annals of Neurology|August 2, 2003
Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseJens Wiltfang, Hermann Esselmann, Alexander Smirnov, et al.
Molecular Psychiatry|October 31, 2024
Serum anti-NMDA receptor antibodies are linked to memory impairment 12 months after strokeFriederike A Arlt, Pia S Sperber, Regina von Rennenberg, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 27, 2007
Impact of vCJD on blood supplyRainer Seitz, Friedger von Auer, Johannes Blümel, et al.
Molecular Neurobiology|March 22, 2017
Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob DiseaseFranc Llorens, Niels Kruse, André Karch, et al.
Acta Neuropathologica|March 19, 2026
A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's diseaseTayyaba Saleem, Wiebke Möbius, Matthias Schmitz, et al.
Nature Neuroscience|September 26, 2017
α-synuclein interacts with PrP<sup>C</sup> to induce cognitive impairment through mGluR5 and NMDAR2BDiana G Ferreira, Mariana Temido-Ferreira, Hugo Vicente Miranda, et al.
Nature Communications|May 12, 2026
Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse modelDavide Caredio, Giovanni Mariutti, Lisa Polzer, et al.
Pageof 36

Showing results (281-290 of 358) with videos related to

Sort By:
Pageof 36
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2021
Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In VivoTobias Thom, Matthias Schmitz, Anna-Lisa Fischer, et al.
Molecular Neurobiology|October 12, 2016
Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform EncephalopathiesAgata Mata, Laura Urrea, Silvia Vilches, et al.
Human Molecular Genetics|April 9, 2016
Identification of new molecular alterations in fatal familial insomniaFranc Llorens, Katrin Thüne, Matthias Schmitz, et al.
Annals of Neurology|August 2, 2003
Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseJens Wiltfang, Hermann Esselmann, Alexander Smirnov, et al.
Molecular Psychiatry|October 31, 2024
Serum anti-NMDA receptor antibodies are linked to memory impairment 12 months after strokeFriederike A Arlt, Pia S Sperber, Regina von Rennenberg, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 27, 2007
Impact of vCJD on blood supplyRainer Seitz, Friedger von Auer, Johannes Blümel, et al.
Molecular Neurobiology|March 22, 2017
Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob DiseaseFranc Llorens, Niels Kruse, André Karch, et al.
Acta Neuropathologica|March 19, 2026
A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's diseaseTayyaba Saleem, Wiebke Möbius, Matthias Schmitz, et al.
Nature Neuroscience|September 26, 2017
α-synuclein interacts with PrP<sup>C</sup> to induce cognitive impairment through mGluR5 and NMDAR2BDiana G Ferreira, Mariana Temido-Ferreira, Hugo Vicente Miranda, et al.
Nature Communications|May 12, 2026
Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse modelDavide Caredio, Giovanni Mariutti, Lisa Polzer, et al.
Pageof 36